Table 3 of Abu-Amero, Mol Vis 2010; 16:2805-2810.

Table 3. Allele frequencies of various LOXL1-SNPs in PEG patients and controls.



SNP I.D.
Nucleotide
change		 Amino
acid
change

Allele		 PEG
patients
(n=93)
Controls
(n=101)

p value
rs1048661 g.5758 G>T R141L G 163 (0.876)• 154 (0.762) 0.0056
rs3825942 g.5794 G>A G153D G 180 (0.968) 165 (0.817) 0.000005
rs28706550 g.25067 A>C N437H A 186 (1) 202 (1) N/A
rs35203737 g.28103 C>A S565Y C 186 (1) 202 (1) N/A
Novel g.25722 C>G D484E C 184 (0.99) 202 (1) N/A
Novel g.28084 T>G Y559D T 185 (0.995) 202 (1) N/A
rs8818 g.30490 C>G - G 141 (0.758) 138 (0.683) 0.126
rs3522 g.30556 C>T - C 116 (0.624) 125 (0.619) 0.994
rs41429348 g.6212 C>T - C 186 (1) 202 (1) N/A
rs12906373 g.6272 C>T - C 186 (1) 202 (1) N/A
rs41435250 g.6296 G>T - G 186 (1) 202 (1) N/A
rs13329473 g.25737 C>T - C 186 (1) 202 (1) N/A

LOXL1 indicates lysyl oxidase-like 1; PEG indicates exfoliation glaucoma. Alleles in bold were considered the risk alleles in calculating p value. Nucleotide are numbered as in GenBank accession number NG_011466. •Numbers in parenthesis represent the allele frequency. Novel indicates not previously reported. N/A indicates not applicable.

Abu-Amero, Mol Vis 2010; 16:2805-2810. http://www.molvis.org/molvis/v16/a300

©2010 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535